The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NRG Oncology BR005: Phase II trial assessing accuracy of tumor bed biopsies (Bx) in predicting pathologic response in patients (Pts) with clinical/radiological complete response (CR) after neoadjuvant chemotherapy (NCT) in order to explore the feasibility of breast-conserving treatment (BCT) without surgery.
 
Mark Basik
Honoraria - Novartis
Consulting or Advisory Role - NanoString Technologies; Novartis
 
Joseph P. Costantino
Consulting or Advisory Role - Pfizer
 
Jennifer F. De Los Santos
Honoraria - Varian Medical Systems
 
Heidi Umphrey
Employment - MidSouth Imaging
Research Funding - GE Healthcare; Philips Healthcare
 
Thomas B. Julian
No Relationships to Disclose
 
Eleftherios P. Mamounas
Honoraria - Genentech/Roche; Genomic Health
Consulting or Advisory Role - bioTheranostics; Celcuity; Genomic Health; GRAIL; Macrogenics
Speakers' Bureau - Genentech/Roche; Genomic Health
Travel, Accommodations, Expenses - Celgene; Genentech/Roche; Genomic Health
 
Julia R. White
Honoraria - Qfix
Research Funding - Intraop Medical (Inst)
Travel, Accommodations, Expenses - Qfix
 
Peter C. Lucas
Stock and Other Ownership Interests - Amgen
 
Jamie L. Wagner
No Relationships to Disclose
 
Judy Angela Tjoe
No Relationships to Disclose
 
Alastair Mark Thompson
Honoraria - Novartis (I)
Research Funding - Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Novartis (I)
 
Norman Wolmark
Research Funding - AbbVie (Inst); AbbVie (Inst); Bayer (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Puma Biotechnology (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - AbbVie (Inst)
Travel, Accommodations, Expenses - Abbvie; AbbVie; Genentech; GHI Pharma; Sanofi